| Title |
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
|
|---|---|
| Published in |
Journal of Neuro-Oncology, December 2009
|
| DOI | 10.1007/s11060-009-0057-4 |
| Pubmed ID | |
| Authors |
Timothy C. Ryken, Michael McDermott, Paula D. Robinson, Mario Ammirati, David W. Andrews, Anthony L. Asher, Stuart H. Burri, Charles S. Cobbs, Laurie E. Gaspar, Douglas Kondziolka, Mark E. Linskey, Jay S. Loeffler, Minesh P. Mehta, Tom Mikkelsen, Jeffrey J. Olson, Nina A. Paleologos, Roy A. Patchell, Steven N. Kalkanis |
| Abstract |
Do steroids improve neurologic symptoms in patients with metastatic brain tumors compared to no treatment? If steroids are given, what dose should be used? Comparisons include: (1) steroid therapy versus none. (2) comparison of different doses of steroid therapy. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 2 | 33% |
| Canada | 1 | 17% |
| Spain | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 368 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 1% |
| Ecuador | 1 | <1% |
| Brazil | 1 | <1% |
| Belgium | 1 | <1% |
| Canada | 1 | <1% |
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 357 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 56 | 15% |
| Researcher | 50 | 14% |
| Student > Postgraduate | 45 | 12% |
| Student > Master | 33 | 9% |
| Student > Doctoral Student | 27 | 7% |
| Other | 91 | 25% |
| Unknown | 66 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 213 | 58% |
| Neuroscience | 14 | 4% |
| Agricultural and Biological Sciences | 12 | 3% |
| Biochemistry, Genetics and Molecular Biology | 9 | 2% |
| Nursing and Health Professions | 7 | 2% |
| Other | 29 | 8% |
| Unknown | 84 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2018.
All research outputs
#3,326,198
of 23,613,071 outputs
Outputs from Journal of Neuro-Oncology
#279
of 3,041 outputs
Outputs of similar age
#17,282
of 169,090 outputs
Outputs of similar age from Journal of Neuro-Oncology
#3
of 23 outputs
Altmetric has tracked 23,613,071 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,041 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,090 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.